Study of TV-1106 in Growth Hormone-Deficient Adults
Public ClinicalTrials.gov record NCT02410343. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy, Safety and Tolerability Study of TV-1106 in Growth Hormone-Deficient Adults Who Are Not Current Users of rhGH Treatment
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to determine the efficacy of 6 months of treatment with TV-1106 compared with placebo on body fat composition.
Study identification
- NCT ID
- NCT02410343
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 14 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2015 (Actual)
- Primary completion
- Dec 31, 2015 (Actual)
- Completion
- Dec 31, 2015 (Actual)
- Last update posted
- Jan 24, 2022
2015
United States locations
- U.S. sites
- 25
- U.S. states
- 10
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Teva Investigational Site 13102 | Artesia | California | 90701 | — |
| Teva Investigational Site 13127 | Fountain Valley | California | 33155-6541 | — |
| Teva Investigational Site 13126 | Fountain Valley | California | 92708 | — |
| Teva Investigational Site 13103 | Miami | Florida | 33126 | — |
| Teva Investigational Site 13118 | Miami | Florida | 33130 | — |
| Teva Investigational Site 13123 | Miami | Florida | 33145 | — |
| Teva Investigational Site 13492 | Miami | Florida | 33155-6541 | — |
| Teva Investigational Site 13114 | Miami Lakes | Florida | 33016 | — |
| Teva Investigational Site 13100 | Pembroke Pines | Florida | 33024 | — |
| Teva Investigational Site 13121 | West Palm Beach | Florida | 33401 | — |
| Teva Investigational Site 13104 | Chicago | Illinois | 60612 | — |
| Teva Investigational Site 13124 | Evansville | Indiana | 47714 | — |
| Teva Investigational Site 13101 | Detroit | Michigan | 48202 | — |
| Teva Investigational Site 13112 | Henderson | Nevada | 89052 | — |
| Teva Investigational Site 13113 | Las Vegas | Nevada | 89148 | — |
| Teva Investigational Site 13109 | Brooklyn | New York | 11235 | — |
| Teva Investigational Site 13494 | New York | New York | 10016 | — |
| Teva Investigational Site 13106 | New York | New York | 10032 | — |
| Teva Investigational Site 13096 | Asheville | North Carolina | 28803 | — |
| Teva Investigational Site 13108 | Pittsburgh | Pennsylvania | 15212 | — |
| Teva Investigational Site 13110 | Arlington | Texas | 76014 | — |
| Teva Investigational Site 13125 | Dallas | Texas | 75218 | — |
| Teva Investigational Site 13097 | Houston | Texas | 77079 | — |
| Teva Investigational Site 13107 | Houston | Texas | 77084 | — |
| Teva Investigational Site 13120 | Houston | Texas | 77090 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02410343, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 24, 2022 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02410343 live on ClinicalTrials.gov.